Professor | Zhen Liu | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Zhen Liu

Contact Information

7102981@qq.com

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	Guangzhou Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	PhD: Southern Medical University Guangdong Province Special Support Plan 'Young Top-notch Talent in Scientific and Technological Innovation' Guangdong Province Outstanding Young Teacher in Higher Education
Awards	Guangdong Province Special Support Plan 'Young Top-notch Talent in Scientific and Technological Innovation' Guangdong Province Outstanding Young Teacher in Higher Education Guangzhou 'Pearl River Science and Technology New Star' Guangzhou High-level Talent Guangzhou Medical University 'Nanshan Scholar Outstanding Talent'

University/Lab Affiliation and Title

Guangzhou Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

PhD: Southern Medical University
Guangdong Province Special Support Plan 'Young Top-notch Talent in Scientific and Technological Innovation'
Guangdong Province Outstanding Young Teacher in Higher Education

Awards

Guangdong Province Special Support Plan 'Young Top-notch Talent in Scientific and Technological Innovation'
Guangdong Province Outstanding Young Teacher in Higher Education
Guangzhou 'Pearl River Science and Technology New Star'
Guangzhou High-level Talent
Guangzhou Medical University 'Nanshan Scholar Outstanding Talent'

Areas of Focus	Tumor Pathogenesis Tumor Drug Resistance Tumor Translational Medicine
Publications	HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma., Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z., 2019 miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin., Y Zhen, W Fang, M Zhao, R Luo, Y Liu, Q Fu, Y Chen, C Cheng, Y Zhang, Z Liu., 2017 Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma., Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, Liu C, Xie YY, Zuo S, Liu Z, Liu Z, Fang WY., 2020 SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma., Y Li, YM Lv, C Cheng, Y Huang, L Yang, JJ He, XY Tao, YY Hu, YT Ma, Y Su, LY Wu, GF Yu, QP Jiang, S Liu, X Liu, Z Liu*., 2020

Areas of Focus

Tumor Pathogenesis
Tumor Drug Resistance
Tumor Translational Medicine

Publications

HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma., Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z*., 2019
miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin., Y Zhen, W Fang, M Zhao, R Luo, Y Liu, Q Fu, Y Chen, C Cheng, Y Zhang, Z Liu*., 2017
Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma., Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, Liu C, Xie YY, Zuo S, Liu Z, Liu Z*, Fang WY*., 2020
SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma., Y Li, YM Lv, C Cheng, Y Huang, L Yang, JJ He, XY Tao, YY Hu, YT Ma, Y Su, LY Wu, GF Yu, QP Jiang, S Liu, X Liu, Z Liu*., 2020

Tumor Pathogenesis Drug Resistance Translational Medicine Cancer Oncology Biomarkers Therapy Genetics Molecular Biology

Yan Sun - Peking University

Xiaojuan Du - Peking University

Bai Yun - Peking University

View All

Personal Information